/en/sysglobalassets/global-assets/capabilities/lens_thick_light.svg

Healthcare Innovation

Investing in the world’s health

Our approach

The fund

The team

Insights

Across the world, we are living longer – this is due to rapid advances in healthcare science, new procedures and better use of data science and computing power. At the same time, an increasing focus on healthy living and improved well-being has never been more in the spotlight. 2020 has definitely been a significant year for healthcare innovation, changing its landscape forever.

Although traditionally seen as a source of relatively defensive growth, the rapid pace of change across the healthcare sector are opening up a new world of healthcare investment opportunities.

Introduction to healthcare innovation

Find out about the drivers behind longer, healthier lives.

An exciting time for healthcare

John Bowler, Global Healthcare portfolio manager shares his insight

Schroder ISF* Healthcare Innovation

A fund that gives investors a broad exposure to companies shaping the world of healthcare

*Schroder International Selection Fund is referred to as Schroder ISF throughout

About the fund

Schroder Healthcare Innovation team

A quick overview of the team behind Schroder ISF Healthcare Innovation

Meet the team

What are the long-term prospects for healthcare investing post Covid-19?

The pandemic has shone a spotlight on healthcare but what happens when a vaccine is found? We asked Schroders’ investment experts for their views on the sector’s long-term prospects.

Tell me more

A deeper look into Schroders' Global Transformation Range

Learn about the suite of funds that give you exposure to the most powerful themes that are shaping the world we live in.

Tell me more

Latest Healthcare Innovation articles

Risk Considerations:

Concentration risk: The fund may be concentrated in a limited number of geographical regions, industry sectors, markets and/or individual positions. This may result in large changes in the value of the fund, both up or down.

Counterparty risk: The fund may have contractual agreements with counterparties. If a counterparty is unable to fulfil their obligations, the sum that they owe to the fund may be lost in part or in whole.

Currency risk: The fund may lose value as a result of movements in foreign exchange rates.

Derivatives risk: efficient portfolio management: Derivatives may be used to manage the portfolio efficiently. A derivative may not perform as expected, may create losses greater than the cost of the derivative and may result in losses to the fund.

IBOR Risk: The transition of the financial markets away from the use of interbank offered rates (IBORs) to alternative reference rates may impact the valuation of certain holdings and disrupt liquidity in certain instruments. This may impact the investment performance of the fund.

Liquidity risk: in difficult market conditions, the fund may not be able to sell a security for full value or at all. This could affect performance and could cause the fund to defer or suspend redemptions of its shares.

Market Risk: The value of investments can go up and down and an investor may not get back the amount initially invested.

Operational risk: Operational processes, including those related to the safekeeping of assets, may fail. This may result in losses to the fund.

Performance risk: Investment objectives express an intended result but there is no guarantee that such a result will be achieved. Depending on market conditions and the macro economic environment, investment objectives may become more difficult to achieve.

Important Information: The views and opinions contained herein are those of the authors, and may not necessarily represent views expressed or reflected in other Schroders communications, strategies or funds. This webpage is intended to be for information purposes only. The material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The material is not intended to provide, and should not be relied on for, accounting, legal or tax advice, or investment recommendations. Information herein is believed to be reliable but Schroders does not warrant its completeness or accuracy. No responsibility can be accepted for errors of fact or opinion. Reliance should not be placed on the views and information in the webpage when taking individual investment and/or strategic decisions. Past performance is not a guide to future performance and may not be repeated. The value of investments and the income from them may go down as well as up and investors may not get back the amounts originally invested. The data contained in this webpage has been obtained from sources we consider to be reliable. No responsibility can be accepted for errors of fact and the data should be independently verified before further publication or use. The sectors shown are for illustrative purposes only and not to be considered a recommendation to buy or sell. Exchange rate changes may cause the value of any overseas investments to rise or fall.

This content is issued by Schroder Investment Management (Europe) S.A., 5, rue Höhenhof, L-1736 Senningerberg, Luxembourg. Registered No. B 37.799.

Schroders is a world-class asset manager operating from 37 locations across Europe, the Americas, Asia, the Middle East and Africa.

Worldwide locations

For any further questions, please use our online contact form.

Contact Form

Please note that only the following funds are authorised for distribution in Malta. All other funds mentioned are for information purposes only.

Schroder International Selection Fund is referred to as Schroder ISF throughout this website.

This website is exclusively directed at professional investors pursuant to the MiFID legislation. According to this, professional investors are investors with the necessary competence and experience including, for example, fund managers, sales partners and finance intermediaries. If you should not come under this category, we advise against visiting this website.

Schroder Investment Management (Europe) S.A. is the management company ("Management Company") of Schroder International Selection Fund ("Schroder ISF"), Schroder GAIA, Schroder Special Situations Fund ("Schroder SSF") and Schroder GAIA II (each a "Company" and jointly the "Companies").

The Companies are open investment companies with an umbrella structure established as "Société Anonyme" under the laws of the Grand Duchy of Luxembourg and having the status of an investment company with variable capital (Société d'Investissement à Capital Variable, SICAV). Schroder ISF, Schroder GAIA and Schroder SSF have the status of an SICAV pursuant to Part I of the Law on Organisms for Joint Investments passed on 17 December 2010. Schroder AS and Schroder GAIA II are subject to the provisions of Part II of the Law on Organisms for Joint Investments passed on 17 December 2010. The Companies operate sub-funds which have a specific portfolio of assets and liabilities within the company and which own net assets (the "Funds"). The Management Company is subject to the rules of Directive 2010/43/EU on management companies as implemented in Luxembourg Law.

The Management Company merely provides information on its products and services and does not give investment advice on the basis of individual circumstances. If you are not sure whether an investment is suitable for you, it is recommended to seek the advice of an independent financial consultant.

The contents provided through this website are legal documents as well as marketing material for professional investors and advisors. The information and materials on this website may be provided in more than one language.

Before joining this website, kindly read the Legal Information and the Privacy Statement.

Schroders uses cookies to personalise and improve your site experience. You can accept all cookies by selecting 'I agree' and continuing to browse the site or you can "Manage cookies" to apply only the categories of your choosing. Find out more details on how we use your information in our “Cookie Policy”

Long reads

Select a region

Select a location

Select a site

Retail Investors

Retirement Services

Mutual fund investment

Private Investor

Real Estate

Asset management

Wealth management

Select a region

Select a location

Select a site

Retail Investors

Retirement Services

Mutual fund investment

Private Investor

Real Estate

Asset management

Wealth management

Schroders in Malta

SCHRODERS Global

LATEST CAREERS

Product Operations Specialist

Reconciliation Manager

Schroders Returner Programme - Sustainable Investment Analyst

LATEST NEWS

Can China really become carbon net zero by 2060?

Why profits are in the driving seat for US equity returns this year

China’s new growth target: what does it mean for markets?

Healthcare Innovation

Investing in the world’s health

Introduction to healthcare innovation

An exciting time for healthcare

What are the long-term prospects for healthcare investing post Covid-19?

A deeper look into Schroders' Global Transformation Range

Latest Healthcare Innovation articles

Select a region

Select a location

Select a site

Retail Investors

Retirement Services

Mutual fund investment

Private Investor

Real Estate

Asset management

Wealth management

Select a region

Select a location

Select a site

Retail Investors

Retirement Services

Mutual fund investment

Private Investor

Real Estate

Asset management

Wealth management

Schroders in Malta

SCHRODERS Global

LATEST CAREERS

Product Operations Specialist

Reconciliation Manager

Schroders Returner Programme - Sustainable Investment Analyst

LATEST NEWS

Can China really become carbon net zero by 2060?

Why profits are in the driving seat for US equity returns this year

China’s new growth target: what does it mean for markets?

China’s new growth target: what does it mean for markets?

Can China really become carbon net zero by 2060?

IncomeIQ

incomeIQ

Related Search

Healthcare Innovation

Investing in the world’s health

Introduction to healthcare innovation

An exciting time for healthcare

What are the long-term prospects for healthcare investing post Covid-19?

A deeper look into Schroders' Global Transformation Range

Latest Healthcare Innovation articles

Please accept the following legal notice: